Levetiracetam Tablet, Film Coated
Product Images NDC 50228-471

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 50228-471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A bar graph showing the percentage of patients by treatment group. It compares placebo with Levetiracetam oral tablets at doses of 1000 mg/day and 3000 mg/day. The y-axis represents percentage of patients, with placebo at 7.4%, Levetiracetam 1000 mg/day at 37.1%, and Levetiracetam 3000 mg/day at 39.6%.*

FDA Label Image

Figure2 (Figure2)

A bar chart comparing the percentage of patients across three groups: Placebo (6.3%), Levetiracetam Tablet 1000 mg/day (20.8%), and Levetiracetam Tablet 3000 mg/day (35.2%). The vertical axis represents the percentage of patients, ranging from 0% to 45%. The horizontal axis categorizes the three groups by treatment type and dosage, with the number of patients (N) indicated for each group.*

FDA Label Image

Figure3 (Figure3)

A bar chart comparing the percentage of patients between placebo and Levetiracetam 3000 mg/day groups. The chart shows higher patient percentage in the Levetiracetam group (39.4%) versus placebo (14.4%). The x-axis labels group names and sample sizes; y-axis represents percentage of patients from 0% to 45%.*

FDA Label Image

Figure4 (Figure4)

A bar graph comparing the percentage of patients for Placebo (19.6%) and Levetiracetam Tablet (44.6%). The x-axis labels the groups with sample sizes (N=97 for Placebo, N=101 for Levetiracetam Tablet), and the y-axis shows the percentage of patients from 0% to 45%. The Levetiracetam bar is significantly higher, marked with an asterisk.*

FDA Label Image

Figure5 (Figure5)

A bar chart comparing the percentage of patients in two groups: Placebo and Levetiracetam. The vertical axis represents the percentage of patients, with Placebo showing 19.6% and Levetiracetam showing 43.1%. Patient counts for each group are shown as N=51 for Placebo and N=58 for Levetiracetam.*

FDA Label Image

Figure6 (Figure6)

A bar graph comparing the percentage of patients for two groups: Placebo (N=84) at 45.2% and Levetiracetam (N=79) at 72.2%. The y-axis represents the percentage of patients, ranging from 0% to 100%.*

FDA Label Image

1000mg-30s (Levetiracetam Tabs 1000mg 30s)

Label for Levetiracetam Tablets USP 1000 mg oral film-coated tablets. The bottle contains 30 tablets. Manufactured by ScieGen Pharmaceuticals, Inc. The label includes storage instructions, dosage directions to see package insert, a barcode, and a note that it is Rx only. It also advises dispensing a medication guide to the patient and keeping medication out of children's reach.*

FDA Label Image

1000mg-500s (Levetiracetam Tabs 1000mg 500s)

Levetiracetam Tablets USP 1000 mg film-coated tablets label from ScieGen Pharmaceuticals, Inc. The label indicates the strength as 1000 mg and the package contains 500 tablets. It includes storage instructions, a barcode, and state that it is prescription only (Rx only). The manufacturer's information is ScieGen Pharmaceuticals, Inc., Hauppauge, NY.*

FDA Label Image

Levetiracetam Tabs 1000mg 60s

Levetiracetam Tablets USP 1000 mg film-coated tablets label from ScieGen Pharmaceuticals, Inc. The label shows packaging for 60 oral tablets with an NDC number 50228-473-60. It includes storage instructions, dosage referral to package insert, and pharmacist dispensing guidance. The label features a barcode and the ScieGen logo at the bottom.*

FDA Label Image

Levetiracetam Tabs 250mg 1000s

Label for Levetiracetam Tablets, USP 250 mg, film-coated oral tablets. The label indicates a package size of 1,000 tablets and includes storage instructions to store at 25°C (77°F) with permitted excursions, and to keep the medication out of reach of children. It is manufactured by ScieGen Pharmaceuticals, Inc., Hauppauge, NY. The label features a barcode and notes the product is Rx only.*

FDA Label Image

Levetiracetam Tabs 250mg 120s

Label for Levetiracetam Tablets USP, 250 mg oral film-coated tablets by ScieGen Pharmaceuticals, Inc. The label indicates a package quantity of 120 tablets, includes storage instructions to keep at 25°C with allowed excursions up to 30°C, and advises dispensing with a medication guide. The NDC number is partially visible as 50228-470-12.*

FDA Label Image

Levetiracetam Tabs 250mg 30s

Label for Levetiracetam Tablets, USP 250 mg, oral film-coated tablets. The label shows a package size of 30 tablets and indicates prescription use (Rx only). Manufacturer is ScieGen Pharmaceuticals, Inc., Hauppauge, NY. Includes storage instructions and a barcode on the right side.*

FDA Label Image

Levetiracetam Tabs 250mg 500s

Levetiracetam Tablets, USP 250 mg film-coated tablets in a container of 500 tablets. The label includes storage instructions to keep at 25°C (77°F) with permitted excursions, and cautions to dispense in a child-resistant container. Manufactured by ScieGen Pharmaceuticals, Inc., Hauppauge, NY. The label also shows the NDC 50228-470-05 and a barcode.*

FDA Label Image

Levetiracetam Tabs 500mg 1000s

Levetiracetam Tablets, USP 500 mg film-coated tablets label showing a package size of 1,000 tablets. The label includes storage instructions, a barcode, and is manufactured by ScieGen Pharmaceuticals, Inc., Hauppauge, NY. The label also states Rx only and emphasizes dispensing a Medication Guide to patients.*

FDA Label Image

Levetiracetam Tabs 500mg 120s

Label for Levetiracetam Tablets, USP 500 mg film-coated tablets by ScieGen Pharmaceuticals, Inc. The label includes dosage storage instructions, packaging details, and a barcode. It indicates a package size of 120 tablets, with prescription-only status. The label also advises dispensing the medication guide with the product.*

FDA Label Image

Levetiracetam Tabs 500mg 30s

Levetiracetam 500 mg film-coated tablets label, USP, manufactured by ScieGen Pharmaceuticals, Inc. The label includes dosage form and strength, package quantity of 30 tablets, storage instructions, and a barcode. It indicates the product is prescription only (Rx only) and includes a reminder for pharmacists to dispense a medication guide to patients.*

FDA Label Image

Levetiracetam Tabs 500mg 500s

Label for Levetiracetam Tablets, USP 500 mg by ScieGen Pharmaceuticals, Inc. The film-coated tablets are available in a bottle containing 500 tablets. The label includes storage instructions, a barcode, and states the product is prescription only (Rx only).*

FDA Label Image

Levetiracetam Tabs 750mg 120s

Label for Levetiracetam Tablets, USP 750 mg by ScieGen Pharmaceuticals, Inc. The label indicates a quantity of 120 film-coated oral tablets. It includes storage instructions to keep the product at 25°C (77°F) with permitted excursions, child-resistant packaging advice, and a pharmacist dispensing note. The label displays the NDC 50228-472-12 and a barcode.*

FDA Label Image

750mg-30s (Levetiracetam Tabs 750mg 30s)

Levetiracetam Tablets USP 750 mg film-coated tablet label by ScieGen Pharmaceuticals, Inc. The label includes storage instructions, dosage recommendations, and safety warnings. The package contains 30 tablets, indicated for prescription use only. The NDC is 50228-472-30. The label also features a barcode and the note 'NO VARNISH.'*

FDA Label Image

750mg-500s (Levetiracetam Tabs 750mg 500s)

Levetiracetam Tablets, USP 750 mg film-coated tablets label by ScieGen Pharmaceuticals, Inc., containing 500 tablets. The label includes storage instructions, dispensing requirements, and a pharmacist note to provide a Medication Guide. The NDC number 50228-472-05 is displayed along with the manufacturer information from Hauppauge, NY.*

FDA Label Image

Structure (Structure)

Chemical structure of levetiracetam. The image shows a molecular diagram with a pyrrolidone ring connected to an ethyl group and an amide functional group, representing the active ingredient levetiracetam.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.